Are patients with inflammatory bowel disease receiving adequate immunisation?
Copyright © 2020 Elsevier España, S.L.U. All rights reserved..
INTRODUCTION: Inflammatory Bowel Disease (IBD) treatment may increase the risk of infections. Vaccines are part of the comprehensive IBD patient care. The aim of this study was to describe indications and adherence of immunizations in IBD and identify possible associated factors.
METHODS: A cross-sectional, analytic study was conducted in patients from an IBD Program of a tertiary center in Chile, between April - June 2019. Patients were asked to answer a vaccine survey and information also was obtained from the National Immunization Registry. Descriptive and association statistic were used (χ2; p<0.05).
RESULTS: A total of 243 patients were included (148 ulcerative colitis (UC), 86 Crohn's disease (CD) and 9 non-classifiable IBD). Only six patients (2%) of IBD patients received a complete immunization schedule. The highest vaccine rates were against influenza (67%), hepatitis B virus (40%), 13-valent pneumococcal (34%) and 23-polysaccharide pneumococcal (16%). The influenza vaccine rate has significantly increased, reaching 67% in 2019. The survey showed that 23% of patients have not been immunized with any vaccine, mainly due to lack of time, lack of medical prescription and high cost.
CONCLUSIONS: In this cohort, although vaccination rates are higher than previously reported, adherence to IBD immunization program would be improved, being considered since diagnosis by the multidisciplinary team.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Gastroenterologia y hepatologia - 44(2021), 3 vom: 15. März, Seite 198-205 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
¿Están recibiendo los pacientes con enfermedad inflamatoria intestinal una adecuada inmunización? |
|---|
| Beteiligte Personen: |
Quera, Rodrigo [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 04.11.2021 Date Revised 04.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.gastrohep.2020.06.024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317003097 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317003097 | ||
| 003 | DE-627 | ||
| 005 | 20231225162319.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.gastrohep.2020.06.024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1056.xml |
| 035 | |a (DE-627)NLM317003097 | ||
| 035 | |a (NLM)33131901 | ||
| 035 | |a (PII)S0210-5705(20)30303-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Quera, Rodrigo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Are patients with inflammatory bowel disease receiving adequate immunisation? |
| 246 | 3 | 3 | |a ¿Están recibiendo los pacientes con enfermedad inflamatoria intestinal una adecuada inmunización? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.11.2021 | ||
| 500 | |a Date Revised 04.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a INTRODUCTION: Inflammatory Bowel Disease (IBD) treatment may increase the risk of infections. Vaccines are part of the comprehensive IBD patient care. The aim of this study was to describe indications and adherence of immunizations in IBD and identify possible associated factors | ||
| 520 | |a METHODS: A cross-sectional, analytic study was conducted in patients from an IBD Program of a tertiary center in Chile, between April - June 2019. Patients were asked to answer a vaccine survey and information also was obtained from the National Immunization Registry. Descriptive and association statistic were used (χ2; p<0.05) | ||
| 520 | |a RESULTS: A total of 243 patients were included (148 ulcerative colitis (UC), 86 Crohn's disease (CD) and 9 non-classifiable IBD). Only six patients (2%) of IBD patients received a complete immunization schedule. The highest vaccine rates were against influenza (67%), hepatitis B virus (40%), 13-valent pneumococcal (34%) and 23-polysaccharide pneumococcal (16%). The influenza vaccine rate has significantly increased, reaching 67% in 2019. The survey showed that 23% of patients have not been immunized with any vaccine, mainly due to lack of time, lack of medical prescription and high cost | ||
| 520 | |a CONCLUSIONS: In this cohort, although vaccination rates are higher than previously reported, adherence to IBD immunization program would be improved, being considered since diagnosis by the multidisciplinary team | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Colitis ulcerosa | |
| 650 | 4 | |a Crohn's disease | |
| 650 | 4 | |a Enfermedad de Crohn | |
| 650 | 4 | |a Enfermedad inflamatoria intestinal | |
| 650 | 4 | |a Immunization | |
| 650 | 4 | |a Inflammatory bowel disease | |
| 650 | 4 | |a Inmunización | |
| 650 | 4 | |a Ulcerative colitis | |
| 650 | 4 | |a Vaccination | |
| 650 | 4 | |a Vacunas | |
| 650 | 7 | |a Diphtheria-Tetanus-Pertussis Vaccine |2 NLM | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 650 | 7 | |a Meningococcal Vaccines |2 NLM | |
| 650 | 7 | |a Pneumococcal Vaccines |2 NLM | |
| 650 | 7 | |a Viral Hepatitis Vaccines |2 NLM | |
| 700 | 1 | |a Simian, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Núñez, Paulina |e verfasserin |4 aut | |
| 700 | 1 | |a Flores, Lilian |e verfasserin |4 aut | |
| 700 | 1 | |a Figueroa, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Ibáñez, Patricio |e verfasserin |4 aut | |
| 700 | 1 | |a Kronberg, Udo |e verfasserin |4 aut | |
| 700 | 1 | |a Lubascher, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Pizarro, Gonzalo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gastroenterologia y hepatologia |d 1993 |g 44(2021), 3 vom: 15. März, Seite 198-205 |w (DE-627)NLM075187280 |x 0210-5705 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2021 |g number:3 |g day:15 |g month:03 |g pages:198-205 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gastrohep.2020.06.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2021 |e 3 |b 15 |c 03 |h 198-205 | ||